Evidence map›Paper›PMID 40169244›Full record

GuidelineGut2025

British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis.

Dermot Gleeson, Rosemary Bornand, Ann Brownlee, Harpreet Dhaliwal, Jessica K Dyson, Janeane Hails, Paul Henderson, Deirdre Kelly, George F Mells, Rosa Miquel and 4 more

Abstract readPractice GuidelineReview
In one paragraph

Guideline in Gut, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. [Medical treatment of portal hypertensive bleeding in cirrhosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  3. Article
  4. Autoantibodies in the follow-up of autoimmune hepatitis.Journal of translational autoimmunity · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dermot GleesonLiver Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK dermot.gleeson@nhs.net.ORCID http://orcid.org/0000-0001-8714-2367
Rosemary BornandSouth Yorkshire AIH Support Group, Sheffield, UK.
Ann BrownleeAIH Support UK, Bath, UK.
Harpreet DhaliwalDepartment of Gastroenterology, Manchester Royal Infirmary, Manchester, UK.
Jessica K DysonLiver Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Janeane HailsDivision of Gastroenterology and Hepatology, Addenbrooke's Hospital, Cambridge, UK.
Paul HendersonRoyal Hospital for Children and Young People, Edinburgh, UK.
Deirdre KellyBirmingham Women's & Children's Hospital, Birmingham, UK.
George F MellsDivision of Gastroenterology and Hepatology, Addenbrooke's Hospital, Cambridge, UK.
Rosa MiquelLiver Histopathology Laboratory, Institute of Liver Studies, King's College London, London, UK.
Ye H OoCentre for Liver and Gastroenterology research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Anthea SuttonSheffield Centre for Health and Related Research, The University of Sheffield, Sheffield, UK.
Andrew YeomanGwent Liver Unit, Royal Gwent Hospital, Newport, UK.
Michael A HeneghanInstitute of Liver Studies, King's College Hospital, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease which, if untreated, often leads to cirrhosis, liver failure and death. The last British Society of Gastroenterology (BSG) guideline for the management of AIH was published in 2011. Since then, our understanding of AIH has advanced in many areas. This update to the previous guideline was commissioned by the BSG and developed by a multidisciplinary group. The aim of this guideline is to review and summarise the current evidence, in order to inform and guide diagnosis and management of patients with AIH and its variant syndromes. The main focus is on AIH in adults, but the guidelines should also be relevant to older children and adolescents.

Indexed as

Hepatitis, AutoimmuneAdolescentAdultChildGastroenterologyHumansImmunosuppressive AgentsUnited KingdomYoung AdultImmunosuppressive Agentsautoimmune hepatitisautoimmune liver diseasedrug toxicityliver

Identifiers

PMID40169244
PMCPMC12421125

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.